Metzenauer P, Barnes N M, Costall B, Gozlan H, Hamon M, Kelly M E, Murphy D A, Naylor R J
ASTA Pharma Aktiengesellschaft, Frankfurt, Germany.
Neuroreport. 1992 Jun;3(6):527-9. doi: 10.1097/00001756-199206000-00019.
The anxiolytic-like potential of anpirtoline was assessed in a mouse light/dark aversion test. Anpirtoline (1.0 ng kg(-1)-1.0 micrograms kg-1 i.p.) reduced the aversive responding of mice. This was detected as an increase in the latency to locate the non-aversive compartment and by decreases in the percentage of the time spent in the dark compartment, and the numbers of rears and line crossings in the dark compartment. In radioligand binding studies anpirtoline displayed submicromolar affinity for 5-HT1A, 5-HT1B and 5-HT3 receptor recognition sites (Ki = 151, 28 and 30 nM, respectively) and more modest affinity for 5-HT2 receptor recognition sites (Ki = 1.48 microM). It is concluded that anpirtoline has a unique spectrum of affinity for 5-HT receptor subtypes, its interaction with which may account for its anxiolytic-like activity.
在小鼠明暗回避试验中评估了安匹托林的抗焦虑样作用。安匹托林(腹腔注射,剂量为1.0纳克/千克 - 1.0微克/千克)减少了小鼠的回避反应。这表现为定位非回避区的潜伏期增加,以及在暗区停留时间的百分比、暗区内的直立次数和穿越次数减少。在放射性配体结合研究中,安匹托林对5-HT1A、5-HT1B和5-HT3受体识别位点表现出亚微摩尔亲和力(Ki分别为151、28和30纳摩尔),对5-HT2受体识别位点的亲和力则较弱(Ki = 1.48微摩尔)。得出的结论是,安匹托林对5-HT受体亚型具有独特的亲和力谱,其与这些受体的相互作用可能是其抗焦虑样活性的原因。